# Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

> **NCT00392938** · — · COMPLETED · sponsor: **University of Washington** · enrollment: 11 (actual)

## Conditions studied

- Metastatic Cancer
- Prostate Cancer

## Interventions

- **DRUG:** antiandrogen therapy
- **DRUG:** docetaxel
- **DIAGNOSTIC_TEST:** C-11 acetate PET scan
- **DIAGNOSTIC_TEST:** F-18 FDG PET scan
- **DIAGNOSTIC_TEST:** Tc-99m bone scan
- **DIAGNOSTIC_TEST:** CT scan of the chest, abdomen and pelvis

## Key facts

- **NCT ID:** NCT00392938
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392938, "Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone". Retrieved via MORVS 2026-10-29 from https://api.morvs.ai/clinical/NCT00392938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*